YU29201A - Derivati tiazola - Google Patents
Derivati tiazolaInfo
- Publication number
- YU29201A YU29201A YU29201A YU29201A YU29201A YU 29201 A YU29201 A YU 29201A YU 29201 A YU29201 A YU 29201A YU 29201 A YU29201 A YU 29201A YU 29201 A YU29201 A YU 29201A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- cell
- well
- tumour
- thiazole
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Virology (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Jedinjenja formule (I) kao i njihove farmaceutski primenljive soli i estri, u kojima R1, R2 i R3 imaju značenja data u zahtevu 1, inhibiraju vezivanje adhezivnih proteina za površinu različitih tipova ćelija i prema tome utiču na interakcije tipa ćelija-ćelija i ćelija-matrica. Oni se mogu primeniti u obliku farmaceutskih preparata (smeša) u suzbijanju (kontroli) ili sprečavanju neoplazmi, metastaziranja tumora, rasta tumora, osteoporoze, Pedžetove bolesti, dijabetske retinopatije, makularne (pegaste) degeneracije, restenoze koja pati vaskularnu intervenciju, psorijaze, artritisa, fibroze, slabljenja (nedostataka) bubrega kao i infekcija prouzrokovanih virusima, bakterijama ili gljivicama.[Compounds of formula (I) as well as pharmaceutically usable salts and esters thereof, wherein R1, R2 and R3 have the significance given in claim 1, inhibit the binding of adhesive proteins to the surface of different types of cell and accordingly influence cell-cell and cell-matrix interactions. They can be used in the form of pharmaceutical preparations in the control or prevention of neoplasms, tumour metastasizing, tumour growth, osteoporosis, Paget's disease, diabetic retinopathy, macular degeneration, restenosis following vascular intervention, psoriasis, arthritis, fibrosis, kidney failure as well as infections caused by viruses, bacteria or fungi.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98119985 | 1998-10-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU29201A true YU29201A (sh) | 2005-06-10 |
Family
ID=8232838
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU29201A YU29201A (sh) | 1998-10-22 | 1999-10-15 | Derivati tiazola |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US6297266B1 (sh) |
| EP (1) | EP1123283B1 (sh) |
| JP (1) | JP3530137B2 (sh) |
| KR (1) | KR100469219B1 (sh) |
| CN (1) | CN1211375C (sh) |
| AR (1) | AR023058A1 (sh) |
| AT (1) | ATE266012T1 (sh) |
| AU (1) | AU760219B2 (sh) |
| BR (1) | BR9914666A (sh) |
| CA (1) | CA2347741C (sh) |
| CO (1) | CO5150186A1 (sh) |
| CZ (1) | CZ20011395A3 (sh) |
| DE (1) | DE69917058T2 (sh) |
| DK (1) | DK1123283T3 (sh) |
| ES (1) | ES2221482T3 (sh) |
| HK (1) | HK1047281A1 (sh) |
| HR (1) | HRP20010275A2 (sh) |
| HU (1) | HUP0104202A3 (sh) |
| ID (1) | ID28356A (sh) |
| IL (1) | IL142090A0 (sh) |
| MA (1) | MA26756A1 (sh) |
| NO (1) | NO20011908D0 (sh) |
| NZ (1) | NZ510676A (sh) |
| PE (1) | PE20001116A1 (sh) |
| PL (1) | PL347427A1 (sh) |
| PT (1) | PT1123283E (sh) |
| RU (1) | RU2214404C2 (sh) |
| TR (1) | TR200101115T2 (sh) |
| WO (1) | WO2000024724A1 (sh) |
| YU (1) | YU29201A (sh) |
| ZA (1) | ZA200102653B (sh) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7125875B2 (en) | 1999-04-15 | 2006-10-24 | Bristol-Myers Squibb Company | Cyclic protein tyrosine kinase inhibitors |
| CZ302788B6 (cs) | 1999-04-15 | 2011-11-09 | Bristol-Myers Squibb Company | ´N-(2-Chlor-6-methylfenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolkarboxamid, jeho použití a farmaceutický prostredek s jeho obsahem |
| DE60128651T2 (de) * | 2000-01-19 | 2008-01-31 | Alteon Inc. | Thiazol-imidazol- und oxazolverbindungen und behandlung von mit proteinalterung verbundenen erkrankungen |
| CA2419820A1 (en) | 2000-08-17 | 2002-02-21 | Lumera Corporation | Design and synthesis of advanced nlo materials for electro-optic applications |
| PT1347971E (pt) | 2000-12-21 | 2006-06-30 | Bristol Myers Squibb Co | Inibidores tiazolilicos de tirosina-cinases da familia tec |
| WO2006032322A1 (en) * | 2004-09-20 | 2006-03-30 | 4Sc Ag | NOVEL HETEROCYCLIC NF-κB INHIBITORS |
| UA103319C2 (en) | 2008-05-06 | 2013-10-10 | Глаксосмитклайн Ллк | Thiazole- and oxazole-benzene sulfonamide compounds |
| WO2010012793A1 (en) * | 2008-08-01 | 2010-02-04 | Bayer Cropscience Sa | Fungicide aminothiazole derivatives |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL95548A0 (en) * | 1989-09-15 | 1991-06-30 | Fujisawa Pharmaceutical Co | Thiazole derivatives,processes for the preparation thereof and pharmaceutical composition containing the same |
| CA2037153A1 (en) * | 1990-03-09 | 1991-09-10 | Leo Alig | Acetic acid derivatives |
| US5273982A (en) | 1990-03-09 | 1993-12-28 | Hoffmann-La Roche Inc. | Acetic acid derivatives |
| US6306840B1 (en) * | 1995-01-23 | 2001-10-23 | Biogen, Inc. | Cell adhesion inhibitors |
| JPH0987237A (ja) * | 1995-09-21 | 1997-03-31 | Kyowa Hakko Kogyo Co Ltd | 芳香族誘導体 |
| EP0928790B1 (en) * | 1998-01-02 | 2003-03-05 | F. Hoffmann-La Roche Ag | Thiazole derivatives |
| SI0928793T1 (en) * | 1998-01-02 | 2002-10-31 | F. Hoffmann-La Roche Ag | Thiazole derivatives |
-
1999
- 1999-10-15 PL PL99347427A patent/PL347427A1/xx not_active Application Discontinuation
- 1999-10-15 ID IDW20010863A patent/ID28356A/id unknown
- 1999-10-15 EP EP99970988A patent/EP1123283B1/en not_active Expired - Lifetime
- 1999-10-15 KR KR10-2001-7004899A patent/KR100469219B1/ko not_active IP Right Cessation
- 1999-10-15 CA CA002347741A patent/CA2347741C/en not_active Expired - Fee Related
- 1999-10-15 CZ CZ20011395A patent/CZ20011395A3/cs unknown
- 1999-10-15 RU RU2001113285/04A patent/RU2214404C2/ru not_active IP Right Cessation
- 1999-10-15 CN CNB998124265A patent/CN1211375C/zh not_active Expired - Fee Related
- 1999-10-15 PT PT99970988T patent/PT1123283E/pt unknown
- 1999-10-15 DE DE69917058T patent/DE69917058T2/de not_active Expired - Fee Related
- 1999-10-15 AT AT99970988T patent/ATE266012T1/de not_active IP Right Cessation
- 1999-10-15 DK DK99970988T patent/DK1123283T3/da active
- 1999-10-15 NZ NZ510676A patent/NZ510676A/xx unknown
- 1999-10-15 AU AU11519/00A patent/AU760219B2/en not_active Ceased
- 1999-10-15 WO PCT/EP1999/007824 patent/WO2000024724A1/en active IP Right Grant
- 1999-10-15 TR TR2001/01115T patent/TR200101115T2/xx unknown
- 1999-10-15 IL IL14209099A patent/IL142090A0/xx unknown
- 1999-10-15 YU YU29201A patent/YU29201A/sh unknown
- 1999-10-15 HU HU0104202A patent/HUP0104202A3/hu unknown
- 1999-10-15 JP JP2000578294A patent/JP3530137B2/ja not_active Expired - Fee Related
- 1999-10-15 ES ES99970988T patent/ES2221482T3/es not_active Expired - Lifetime
- 1999-10-15 BR BR9914666-5A patent/BR9914666A/pt not_active IP Right Cessation
- 1999-10-18 PE PE1999001048A patent/PE20001116A1/es not_active Application Discontinuation
- 1999-10-19 US US09/420,387 patent/US6297266B1/en not_active Expired - Fee Related
- 1999-10-20 AR ARP990105306A patent/AR023058A1/es not_active Application Discontinuation
- 1999-10-20 CO CO99066263A patent/CO5150186A1/es unknown
-
2001
- 2001-03-30 ZA ZA200102653A patent/ZA200102653B/en unknown
- 2001-04-12 HR HR20010275A patent/HRP20010275A2/hr not_active Application Discontinuation
- 2001-04-18 NO NO20011908A patent/NO20011908D0/no not_active Application Discontinuation
- 2001-04-20 MA MA26171A patent/MA26756A1/fr unknown
-
2002
- 2002-12-09 HK HK02108922.4A patent/HK1047281A1/zh unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2257328A1 (en) | Thiazole derivatives | |
| AR024703A1 (es) | Benzazepinonas y quinazolinas | |
| AU7576896A (en) | Lipopolyamines as transfection agents and their pharmaceutical applications | |
| FI952607A (fi) | Farmakologisesti aktiiviset pyridiinijohdannaiset ja menetelmät niiden valmistamiseksi | |
| AP9701039A0 (en) | Derivatives of 2- (2-oxo-ethlidene)-imidazolidin-4-one. | |
| BR9810021A (pt) | Derivados 9-oxima-eritromicina | |
| NO924915L (no) | Sakkarinderivater med inhiberende virkning paa protolytiske enzymer | |
| DE69818286D1 (de) | Pyridylverbindungen und diese enthaltende pharmazeutische zubereitungen | |
| YU29201A (sh) | Derivati tiazola | |
| CA2378834A1 (en) | Pyrazinones, compositions containing such compounds | |
| ES8604711A1 (es) | Un procedimiento para la obtencion de beta-feniletanoles sustituidos. | |
| ATE110707T1 (de) | Milchsäureacylate, ihre salze, ihr herstellungsverfahren und sie enthaltende kompositionen. | |
| MX9708735A (es) | Benzotiazoles y benzoxazoles, composiciones farmaceuticas que contienen estos compuestos y su uso y proceso para prepararlos. | |
| YU60998A (sh) | Derivati tiazola | |
| CA2374902A1 (en) | Aminoalkyl substituted benzopyran derivatives for treating impaired fundic relaxation | |
| SE0400027D0 (sv) | Diarylmethyl piperazine derivatives, preparations thereof and uses thereof | |
| BR0016516A (pt) | Pirróis substituìdos | |
| IL72330A (en) | 3-alkyl-7-pyridyl-1h-triazolo(3,4-a)pyrimidine-5-one derivatives,their preparation and pharmaceutical compositions containing them | |
| MY130851A (en) | S-oxide lipid lowering compounds | |
| ECSP993185A (es) | Derivados de tiazol | |
| ECSP982810A (es) | Derivados de tiazol | |
| DE60127705T2 (de) | Antitumor verbindungen basierend auf der regulierung von protein prenylation | |
| ECSP982811A (es) | Derivados de tiazol | |
| EP1547603A3 (en) | Compositions and methods for use in targeting vascular destruction | |
| JPS56158778A (en) | Amide derivative of ai-77 and pharmaceutically acceptable salt thereof |